Eli Lilly and Company and Rigel Pharmaceuticals recently announced an agreement and strategic collaboration to codevelop and commercialize inhibitors for immunological and neurodegenerative...
HHS and the Department of Defense (DoD) recently purchased an additional 100 million doses of COVID-19 vaccines from both Pfizer and Moderna to boost vaccine supply in the US.
The recent order brings...
In January 2020, prescription drug prices increased for 832 medications by an average of 4.6 percent, the largest increase that has occurred in years, according to a GoodRx analysis.
Of the...
Eli Lilly and Company recently partnered with local health systems to enhance access to crucial COVID-19 antibody therapies.
The partnership will work to launch dedicated infusion center...
Pfizer and the IDA Foundation recently partnered to provide equitable access to quality cancer treatments in nearly 70 developing countries.
Under the partnership agreement, millions of more patients...
GSK and CureVac recently announced a $180.5 million collaboration to jointly develop next-generation mRNA COVID-19 vaccines.
The companies will contribute resources and expertise to research, develop,...
Eight top pharmaceutical companies are moving to systematically enhance their drug development pipeline, with plans to boost access to products in low-and middle-income countries, according to the 2021...
Pfizer and BioNTech recently announced an advanced purchase agreement with COVAX for up to 40 million doses of its mRNA COVID-19 vaccine, BNT162b2.
The first doses of the vaccine are expected to be...
FDA recently approved ViiV Healthcare’s Cabenuva, the first and only complete long-acting injectable HIV treatment for positive adults.
The drug will be administered to HIV-positive adults...
Loxo Oncology, a subsidiary of Eli Lilly and Company, and Merus N.V. recently announced a collaboration and exclusive license agreement to research and develop up to three CD3-engaging T-cell...
Moderna recently announced that Swissmedic, the Swiss Agency for therapeutic products, has authorized its mRNA-based COVID-19 vaccine for use in Switzerland.
The Swiss authorization comes over a month...
Roche recently announced that HHS and the Department of Defense (DoD) will purchase additional doses of Regeneron’s COVID-19 antibody cocktail, casirivimab and imdevimab.
Under the agreement,...
Fujifilm Corporation will invest $40 million to establish a new processing facility to advance viral vector manufacturing and perform cutting-edge research in the field of advanced therapies in the...
FDA recently approved the first generic drug for the treatment of severe hypoglycemia, which may occur in patients with diabetes mellitus.
Amphastar Pharmaceutical’s generic of glucagon...
Moderna recently released a COVID-19 vaccine manufacturing update for its mRNA-based vaccine, mRNA-1273. The company announced that it is increasing its base-case global production estimate from 500 to...
Pfizer and BioNTech recently announced that an additional 100 million doses of their mRNA COVID-19 vaccine will go to 27 European Union (EU) member states this year.
The commitment comes just...
The Trump Administration, through HHS and the Department of Defense (DoD), will purchase an additional 100 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273.
mRNA-1273 would...
Tremeau Pharmaceuticals recently announced that Gurnet Point Capital will fund its non-opioid program to clinically develop its investigational drug, TRM-201.
Additionally, the funding will also...
Moderna recently announced that the Canadian Government will now acquire an additional 20 million doses of its mRNA COVID-19 vaccine, bringing the total to 40 million doses.
The updated...
Bayer recently announced the launch of a cell and gene therapy platform (C>) within its pharmaceutical division.
The platform will further consolidate its emerging leadership in the cell and...
